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Editorial
Long-term dialysis is a life-saving treatment for patients 
with end-stage renal disease (ESRD). In a minority of 
ESRD patients, however, the clinical conditions and 
level of self-sufficiency make the usefulness of dialysis 
questionable; it may even be futile, worsening quality 
of life or simply prolonging the dying process [1]. There 
is actually a substantial risk of death or functional de-
cline within a relatively short period of time in elderly 
patients with advanced chronic kidney disease [2]. In 
high-risk highly dependent patients with renal failure, 
the decision to dialyze or not has little impact on sur-
vival; dialysis in such patients may result in unnecessary 
suffering before their unavoidable death. It is therefore 
reasonable for some patients to choose, in consultation 
with their physician, conservative (i.e. non-dialytic) 
management. In fact, the number of such patients is 
steadily increasing. Provisional estimates indicate that, 
in the UK, about 20% of predialysis patients referred 
for education select conservative management [3]; this 
proportion is comparable to that of our general impres-
sion. Clinical experience suggests that the health care 
needs of this patient population are complex. Good renal 
supportive care includes symptom control, measures to 
retard disease progression and manage complications 
of renal disease, provision of information, advance care 
planning, and addressing wider psychosocial and spiri-
tual needs. Meeting these needs requires a shift from a 
predominantly disease-focused approach to a more 
patient-centered approach. Given the huge burden of 
ESRD and the high cost of treatment, however, there is 
a serious need for solid data that can help in deciding 
whether or not conservative therapy should be recom-
mended over long-term dialysis [4]. In this respect, 
palliative care physicians have an important role to play 
in educating nephrologists about palliative care. 
Dr. Doris Tse’s article in this issue of the Hong Kong 
Journal of Nephrology provides important data for our 
reference, as well as substance for our thinking [5].
In her paper, Dr. Tse describes the renal palliative 
care program developed in a local center as an option 
for those who may not benefit from dialysis or who do 
not prefer dialysis. The program is an interdisciplinary 
one that involves collaboration between palliative and 
renal medicine specialists, with the aim of discussing 
advance care planning related to treatment benefits, 
burdens, predicted prognosis and the patient’s prefer-
ence. Specialist palliative care is also introduced as a 
treatment option.
The result of the program was impressive. Over 1.5 
years, a total of 96 patients were interviewed for advance 
care planning—two thirds of them chose palliative care 
after discussion. Holistic care, including home care in 
some cases, was provided by a multidisciplinary team. 
On the whole, the program was well received by patients 
and their families. Notably, active palliative care while 
forgoing dialysis helped to alleviate the sense of help-
lessness and abandonment; patients and families rarely 
changed their minds after a decision for the non-dialytic 
approach was made.
The program described by Dr. Tse clearly illustrates 
how palliative care could be provided for ESRD patients. 
Much of what the palliative care physician offers is 
prognostic data—both with regard to ESRD and to the 
common comorbidities that set the problem in a larger 
context. Palliative care professionals have a great deal 
to offer ESRD patients and their families. Opportunities 
for advance care planning is discussed by Dr. Tse, which 
aims to provide an open forum where patients, their 
families and nephrologists can discuss the various 
options available to them when they are struggling with 
decisions on whether dialysis would serve to prolong 
life or merely delay death.
Another important message of the article is that 
choosing against dialysis does not equate to choosing 
to have no treatment. In general, as nephrologists, we 
receive little training in the way of palliative care. There 
is good evidence to indicate that symptoms, especially 
pain, are both under-recognized and undertreated in 
renal failure patients, who themselves usually identify 
adequate pain and symptom management as a vital 
component of quality end-of-life care [6]. It is, however, 
important to realize that literature on symptom preva-
lence is largely limited to the dialysis population, and 
little is known about symptoms in the conservatively 
managed patient [7]. It is likely that patients managed 
conservatively have high levels of comorbidity and poor 
functional status, and therefore have a higher overall 
burden of symptoms than dialysis patients. A recently 
published study, the first to be conducted in this popula-
tion, suggests that the prevalence of symptoms in con-
servatively managed patients is high [8].
A few important issues related to the palliative care 
of ESRD patients have not been addressed in Dr. Tse’s 
paper, and further research is needed. First, the life 
expectancy of conservatively treated patients needs to 
be defined. Surprisingly, there is little published data 
on the life expectancy of patients with advanced chronic 
kidney disease who are treated conservatively. In a recent 
study, the reported median overall survival in patients 
with advanced renal failure treated conservatively was 
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around 2 years. Although dialysis is generally associated 
with longer survival in patients aged over 75 years, those 
with multiple comorbidities, ischemic heart disease in 
particular, do not survive longer than those treated 
conservatively [9,10]. To date, there is a paucity of local 
data on the life expectancy of conservatively managed 
ESRD patients.
More importantly, the role of the palliative care 
specialist after the initiation of dialysis has not been 
explored. In addition to being involved in advance care 
planning, palliative care specialists could advise patients 
and families to stop dialysis, and provide support for those 
patients in whom further dialysis is unlikely to meet the 
patient’s goals. At present, around 10% of ESRD patients 
are recorded to die as a result of termination of dialysis, 
presumably due to severe coexisting diseases and poor 
general condition. There is certainly room for improving 
the quality of care of these patients from the participation 
of palliative care physicians. Nonetheless, the program 
outlined by Dr. Tse is a small but significant step towards 
providing better care to patients with kidney diseases, 
and is an example of how holistic care can be achieved 
for our patients.
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